For laboratory research use only. Not for human or animal consumption.
BioIntegrityResearch
Wholesale inquiries

30 lots · 20 products · all ≥99.0% purity

Certificate of Analysis library

The analytical results for every lot we hold a certificate on, with the label claim beside the measured content. Records are permanent — a lot stays published after it sells out, so material referenced in published work stays verifiable. Each entry lists the assay performed, the method, and the measured result exactly as the laboratory reported it.

Current lots

In stock now

RET10VAS0526 · GLP-3 Triple Agonist
10 mL vial · 10 mg claim, 10.4 mg measured · reported 2026-05-21
>99.3%
AOD10VAS0426 · AOD-9604
10 mL vial · 10 mg claim, 10.4 mg measured · reported 2026-05-11
>99.4%
ARA10VAS0426 · ARA-290
10 mL vial · 10 mg claim, 10.1 mg measured · reported 2026-04-30
>99.3%
BGTK1511VAS0426 · KLOW
10 mL vial · 10 mg / 50 mg / 10 mg / 10 mg claim, 10.3 / 52.1 / 10.1 / 9.9 mg measured · reported 2026-04-30
>99.4%
BPC10VBG0326 · BPC-157
10 mL vial · 10 mg claim, 10.1 mg measured · reported 2026-03-25
>99.5%
BPC10VAS0126 · BPC-157
10 mL vial · 10 mg claim, 9.9 mg measured · reported 2026-02-20
>99.5%
RET10VCS0126 · GLP-3 Triple Agonist
10 mL vial · 10 mg claim, 10.2 mg measured · reported 2026-02-20
>99.6%
PT10VAS0126 · PT-141
10 mL vial · 10 mg claim, 9.7 mg measured · reported 2026-02-20
>99.7%
TB10VCS0126 · TB-500
10 mL vial · 10 mg claim, 9.9 mg measured · reported 2026-02-20
>99.2%
MOT20VAS0126 · MOTS-c
10 mL vial · 20 mg claim, 19.5 mg measured · reported 2026-02-20
>99.5%
NAD500VAS0126 · NAD+
10 mL vial · 500 mg claim, 511 mg measured · reported 2026-02-20
>99.5%
EPI100V1125 · Epitalon
10 mL vial · 100 mg claim, 102 mg measured · reported 2025-12-04
>99.0%
PT10N1125 · PT-141
15 mL nasal spray · 10 mg claim, 9.5 mg measured · reported 2025-11-24
>99.0%
PTO10310N1125 · PT-141 / Oxytocin / Tesamorelin
15 mL nasal spray · 10 mg / 3 mg / 10 mg claim, 9.3 / 3.0 / 9.7 mg measured · reported 2025-11-24
>99.0%
KPV10N1125 · KPV
15 mL nasal spray · 10 mg claim, 9.2 mg measured · reported 2025-11-24
>99.0%
TIR40N1125 · GLP-2 Dual Agonist
15 mL nasal spray · 40 mg claim, 37.5 mg measured · reported 2025-11-24
>99.0%
BT1010N1025 · BPC-157 / TB-500
15 mL nasal spray · 10 mg / 10 mg claim, 9.2 / 9.2 mg measured · reported 2025-11-20
>99.0%
OXY10N1125 · PT-141 / Oxytocin
15 mL nasal spray · 5 mg / 10 mg claim, 4.3 / 9.2 mg measured · reported 2025-11-20
>99.0%
SXS1515N1125 · Semax / Selank
15 mL nasal spray · 15 mg / 15 mg claim, 13.9 / 13.7 mg measured · reported 2025-11-20
>99.0%
SEM10V1125 · Semax
10 mL vial · 10 mg claim, 9.7 mg measured · reported 2025-11-13
>99.0%
TIR40V1125 · GLP-2 Dual Agonist
10 mL vial · 40 mg claim, 39.7 mg measured · reported 2025-11-13
>99.0%
CI1010N1125 · CJC-1295 / Ipamorelin
15 mL nasal spray · 10 mg / 10 mg claim, 9.2 / 9.3 mg measured · reported 2025-11-13
>99.0%
TES10N1125 · Tesamorelin
15 mL nasal spray · 10 mg claim, 9.4 mg measured · reported 2025-11-13
>99.0%
RET20N1125 · GLP-3 Triple Agonist
15 mL nasal spray · 20 mg claim, 18.5 mg measured · reported 2025-11-13
>99.0%
TIR20N1125B · GLP-2 Dual Agonist
15 mL nasal spray · 20 mg claim, 19.1 mg measured · reported 2025-11-13
>99.0%
NAD500N1125 · NAD+
15 mL nasal spray · 500 mg claim, 505.5 mg measured · reported 2025-11-13
>99.0%
BT1010V1125 · BPC-157 / TB-500
10 mL vial · 10 mg / 10 mg claim, 9.0 / 9.3 mg measured · reported 2025-11-03
>99.0%
CI710V1125 · CJC-1295 / Ipamorelin
10 mL vial · 7.5 mg / 10 mg claim, 7.3 / 10.1 mg measured · reported 2025-11-03
>99.0%
SS10V1125 · SS-31
10 mL vial · 10 mg claim, 9.3 mg measured · reported 2025-11-03
>99.0%
RET40V1125 · GLP-3 Triple Agonist
10 mL vial · 40 mg claim, 39.5 mg measured · reported 2025-10-23
>99.0%

These are the analytical results as reported by the testing laboratory. The certificates themselves are the laboratory’s documents, supplied per batch rather than published as downloads — a certificate should only ever travel with the material it describes. To request the certificate for a specific lot, open that lot’s record and use the request link, or email info@biointegrityresearch.com.